MedicalKeyhole surgery robot

Toumai

Name: Toumai
Brand: MicroPort MedBot (MicroPort group)

Toumai is a Chinese surgical robot for keyhole operations that a surgeon steers from a console. The surgeon's console can be far away, so it is also used for remote surgery (telesurgery) across countries. MicroPort press release, 17 June 2026

Stage 5 of 5

Regulator-cleared or mass market

Which rule placed it

Evidence: Company-reported only
Human help: None reported
Last milestone: 22 July 2026

01Can I get it?

Yes, in places

Where it works today: Approved in China; CE-marked in the EU for remote surgery since June 2026; also used in South Korea and in remote operations in Africa and Asia. MicroPort press release, 17 June 2026
Published price: No published price in our sources.
Human help: A surgeon controls the robot from a console, nearby or in another country.

02Track record

What has actually happened

Every milestone is dated and links to the page it comes from. Lines marked company-reported rest on the maker's own word.

22 July 2026
Update
MicroPort MedBot, Toumai's maker, said it expected its first-ever half-year profit, of about 28 to 40 million yuan.
MicroPort press release, 22 July 2026Company-reported
7 July 2026
Demo
A surgeon used Toumai to do ten remote weight-loss operations in one session of about 11 hours, linking IRCAD sites in Strasbourg, France and Indore, India.
MicroPort press release, 7 July 2026Company-reported
2 July 2026
Pilot
MicroPort signed a cooperation agreement built around Toumai with Korea University Anam Hospital in South Korea.
MicroPort press release, 2 July 2026Company-reported
17 June 2026
Cleared · sets the stage
Toumai received a CE mark in the European Union for remote surgery in urology, general surgery, chest surgery and gynecology.
MicroPort press release, 17 June 2026Company-reported
24 March 2025
Cleared · sets the stage
China's regulator, the NMPA, approved Toumai SP, a single-port version, for urology, general surgery and gynecology.
MassDevice, 24 Mar 2025Company-reported
28 Oct 2024
Update
Surgeons did six prostate cancer operations with Toumai in Angola, two of them remotely from another site on the same hospital campus. MicroPort said Toumai had been used in more than 200 remote operations worldwide.
MassDevice, 28 Oct 2024Company-reported

03Safety and incidents

What has gone wrong

No crashes, recalls or regulator reports in our sources. That is not proof none happened; we add them when a regulator or trusted outlet reports one.

On video

What it looks like, at stage 5

Videos from the maker show the robot at its best. The stage comes from the dated record above, not from what a video shows.

Maker's video · 25 April 2024Cutting-edge robotic surgery solutions | MicroPort® MedBot™

Maker's video · 25 April 2024Medical technologies that benefit a patient every 5 seconds | MicroPort®

Maker's video · 24 April 2024Medical technologies that benefit a patient every 5 seconds | MicroPort®

Maker's video · 24 April 2024Fostering medical innovation that improves patient outcomes | MicroPort®

Every robot video

How we placed it

The rule, not an opinion

Stages are worked out by published rules from the dated milestones above. We never rate robots, and no maker can pay to change a stage.

5
Regulator-cleared or mass marketThis robot
A regulator has cleared it where approval applies: FDA clearance or approval for a medical robot, a permit to run with no one aboard for a self-driving vehicle, or an FAA approval for routine drone flights. Or: Widely sold: sales in the hundreds of thousands, or a product category you can buy in ordinary shops.
Placed by: Toumai received a CE mark in the European Union for remote surgery in urology, general surgery, chest surgery and gynecology (17 June 2026); China's regulator, the NMPA, approved Toumai SP, a single-port version, for urology, general surgery and gynecology (24 March 2025).
4
Paying customers
Delivered to customers who pay for it, beyond a trial, or a paid service the public can use.
3
Pilot
Working with a named customer in a real setting, as a trial.
2
Pre-orders
Orders, reservations or deposits taken, with nothing delivered yet.
1
Demo only
Shown in videos, staged events or a factory, with no units working for customers.

What we couldn't confirm. The date of the original Chinese (NMPA) approval of the multi-port Toumai, and of any Chinese approval for telesurgery, could not be confirmed (web search ran out). No count of Toumai systems installed was found.

Sources

Cite this page

Robotics Verdict. “Toumai (MicroPort MedBot (MicroPort group)): how far has it got?” roboticsverdict.com/robots/microport-toumai. Checked 19 October 2026.